Figure 2.

Mutational profiles of low grade, non-invasive endometrioid endometrial cancers with and without recurrences.

Targeted massively parallel sequencing was performed for 27 non-recurrent and 9 recurrent endometrioid endometrial cancers. All samples were from the primary tumor, regardless of recurrence status. The most recurrent genes affecting 341–468 cancer-related genes are shown. Mutation types are color coded by the legend. Note that none of the mutations were statistically significantly different between non-recurrent and recurrent ultra-low risk endometrioid endometrial cancers.